PAPI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 4.081
AS - Asia 3.154
EU - Europa 3.059
AF - Africa 272
SA - Sud America 183
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.759
Nazione #
US - Stati Uniti d'America 4.031
VN - Vietnam 967
SG - Singapore 791
CN - Cina 767
IT - Italia 691
GB - Regno Unito 637
DE - Germania 329
SE - Svezia 291
UA - Ucraina 200
FR - Francia 193
HK - Hong Kong 192
IN - India 142
RU - Federazione Russa 130
BR - Brasile 123
CH - Svizzera 122
NL - Olanda 116
IE - Irlanda 104
TG - Togo 100
CI - Costa d'Avorio 72
ZA - Sudafrica 59
FI - Finlandia 57
JP - Giappone 52
EE - Estonia 46
CA - Canada 35
BG - Bulgaria 34
BD - Bangladesh 33
JO - Giordania 31
PH - Filippine 25
TH - Thailandia 24
BE - Belgio 23
KR - Corea 21
PL - Polonia 21
AR - Argentina 20
SC - Seychelles 17
TW - Taiwan 16
ID - Indonesia 14
IQ - Iraq 14
IR - Iran 14
CL - Cile 12
NG - Nigeria 12
GR - Grecia 11
EC - Ecuador 10
ES - Italia 10
HR - Croazia 10
PK - Pakistan 9
SA - Arabia Saudita 9
RO - Romania 8
EG - Egitto 7
TR - Turchia 7
AT - Austria 6
AU - Australia 6
CO - Colombia 6
UZ - Uzbekistan 6
HU - Ungheria 5
MX - Messico 5
PE - Perù 5
CR - Costa Rica 3
CZ - Repubblica Ceca 3
LB - Libano 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
PR - Porto Rico 3
PT - Portogallo 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IL - Israele 2
KZ - Kazakistan 2
NP - Nepal 2
SI - Slovenia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GY - Guiana 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MQ - Martinica 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
SX - ???statistics.table.value.countryCode.SX??? 1
TJ - Tagikistan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.759
Città #
Singapore 540
Southend 540
Ashburn 424
Chandler 363
Fairfield 304
Dong Ket 234
San Jose 234
Santa Clara 219
Hong Kong 177
Hanoi 169
Wilmington 164
Ho Chi Minh City 149
Houston 146
Woodbridge 145
Jacksonville 136
Ann Arbor 134
Princeton 133
Bologna 126
Bern 114
Beijing 112
Cambridge 112
Seattle 110
Dublin 102
Lomé 100
Boardman 76
Abidjan 72
Rome 61
Lauterbourg 60
Westminster 59
Padova 56
Helsinki 54
Nanjing 51
Hefei 48
Council Bluffs 45
Los Angeles 44
New York 43
Tokyo 42
Buffalo 41
Dallas 40
Berlin 38
Haiphong 38
Milan 34
Sofia 34
Amman 31
Da Nang 30
Changsha 29
Dearborn 29
Guangzhou 28
Turin 28
Frankfurt am Main 26
São Paulo 25
Jinan 24
Medford 24
Shenyang 24
Saint Petersburg 23
Brussels 22
Mülheim 22
Florence 20
Shanghai 20
Hebei 19
Nanchang 18
Zhengzhou 17
Jiaxing 16
San Diego 16
Munich 15
Redmond 15
Verona 15
Redwood City 14
Tianjin 14
Falkenstein 13
Hangzhou 13
Phoenix 13
Yubileyny 13
Abeokuta 12
Johannesburg 12
Mahé 12
Toronto 12
Brooklyn 11
Mountain View 11
The Dalles 11
Warsaw 11
Des Moines 10
Fremont 10
Olalla 10
Redondo Beach 10
Seoul 10
Amsterdam 9
Ardabil 9
Bangkok 9
Chicago 9
Düsseldorf 9
Quận Ba 9
Wuhan 9
Fuzhou 8
Jakarta 8
Kunming 8
Montreal 8
Naples 8
Nuremberg 8
San Francisco 8
Totale 6.800
Nome #
Effetti co-cancerogeni della vitamina E a livello prostatico 470
Co-carcinogenic effects of vitamin E in prostate 287
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro 258
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 250
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 249
Co-mutagenic and pro-oxidant effects of Vitamin E promotes DNA damage and cell transformation in prostate 245
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells 244
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion 234
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians 228
Carbonic anhydrase 9 mRNA/microRNA34a interplay in hypoxic human mammospheres 225
Kaiware Daikon (Raphanus sativus, L.) Extract: a Naturally Multipotent Chemopreventive Agent 220
A Ligand of Retinoid X Receptor Overcome Multidrug Resistance in Human Colon Carcinoma LoVomdr Cell Line 213
Peroxisome Proliferator Activated Receptor-α/Hypoxia Inducible Factor-1α Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells 213
Cytotoxic and Antioxidant Activity of 4-Methylthio-3-butenyl Isothiocyanate from Raphanus sativus L. (Kaiware Daikon) Sprouts 211
Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells. 205
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. 205
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells 203
PPARγ and RXR Ligands Disrupt the Inflammatory Cross-talk in the Hypoxic Breast Cancer Stem Cells Niche. 200
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 198
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator activated receptor-gamma 195
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 191
(-)-epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line 190
Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue 190
Nuclear receptors agonists exert opposing effects on the inflammation-dependent survival of breast cancer stem cells. 182
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines 182
ANTITUMORAL EFFICACY OF RETINOIDS ON HUMAN MULTIDRUG RESISTANT COLON CARCINOMA (LOVO MDR) AND LEUKEMIA (HL60- MDR) CELL LINES 181
ANTITUMORAL EFFECT OF RETINOIDS: A COMPARISON BETWEEN ALL TRANS RETINOIC ACID AND IIF, A SPECIFIC LIGAND OF RXR 180
Antitumoral effect of retinoids on two human bladder cancer cell lines 176
6-OH-11-hydroxyphenantrene and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells 169
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator-activated receptor gamma 167
Antitumoral effect of retinoids on two human bladder cancer cell lines 161
Search for multidrug resistance modulators: effects of retinoids in human colon carcinoma cells 160
Tumor invasiveness in the fibrosarcoma cell line HT-1080: effect of retinoids 159
Antitumoral efficacy of retinoids on human multidrug resistance colon carcinoma (LoVoMDR) and leukemia (HL-60 MDR) cell lines 159
Enhanced effects of PPARγ ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells. 159
Epigenetic Modifiers as Anticancer Drugs: Effectiveness of Valproic Acid in Neural Crest-derived Tumor Cells 158
Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in U87MG human glioblastoma cell line, 156
Is somatostatin a physiological regulator of human trophoblast functions? 154
Polymeric Micelles Using Pseudo-Amphiphilic Block Copolymers 153
Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue 150
Cytotoxic and antioxidant activity of freeze-dried extract from Japanese daikon sprout (Raphanus sativus, L) 148
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells 148
Role of nuclear receptors in breast cancer stem cells 148
Polymeric micelles using pseudo-amphiphilic block copolymers and their cellular uptake 145
Growth Inhibition and Proapoptotic Activity Induction by IIF and Valproic Acid on RA-resistant Leukemia Cells. 144
PPAR-alpha nuclear receptor/ApoE axis: a new target of Breast Cancer Stem Cells 143
Anti-invasive Effects and Proapoptotic Activity Induction by the Rexinoid IIF and Valproic Acid in Combination on Colon Cancer Cell Lines. 142
EFFECTS OF RETINOIDS ON DRUG SENSITIVE AND MULTIDRUG RESISTANT HUMAN COLON CARCINOMA CELLS 140
Growth inhibition and proapototic activity induction by the retinoid IIF and valproic acid on HT-29 colon cancer cell line 139
PPARγ and retinoid X receptor ligands are potent antitumoral agents in the glioblastoma cell line U87MG 138
Retinoid Receptor Ligands are Potent Anti-inflammatory Agents in Breast Cancer Stem Cells Model 138
Inhibitory effect of the retinoid IIF on cancer cell invasion mediated by the down regulation of matrix metalloproteinases expression in human glioblastoma cells 133
Trattamento di cellule MCF-7 resistenti al tamoxifene con (-)-epigallocatechina-3-gallato 132
PPARgamma and RXRligans act sinergistically as potent antineoplastic agents in vitro and in vivo glioma models 120
Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein 120
Tumor invasiveness in the fibrosarcoma cell line HT-1080: effect of retinoids 117
The rexinoid 6-OH-11-O-hydroxyphenantrene induces apoptosis of human osteosarcoma and mesenchymal stem cells. 113
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. 113
Retinoids Hamper Inflammation in Normal and Cancer Epithelial Cell Lines. 109
null 91
XXI Convegno Annuale ABCD (Stress cellulare: sopravvivenza ed apoptosi), Atti convegno 86
null 79
Totale 10.916
Categoria #
all - tutte 27.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.194 102 72 56 80 84 62 25 82 28 115 251 237
2022/20231.575 137 246 85 179 87 112 31 81 279 45 122 171
2023/2024435 22 60 19 51 37 90 32 36 7 32 31 18
2024/20251.441 67 202 135 122 287 83 71 40 7 130 14 283
2025/20263.126 250 181 230 174 401 177 271 140 792 240 106 164
2026/202778 78 0 0 0 0 0 0 0 0 0 0 0
Totale 10.916